{"id":"edc-cons-ufo","phase":"phase_1","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"active","trials":["NCT03816137"],"aliases":[],"patents":[],"pricing":[],"timeline":[],"aiSummary":"EDC ConS UFO is an intervention being studied in a clinical trial for HIV-1-infection. It is one of the interventions being tested in a study at Imperial College London to model the interaction between rationally-designed synthetic model viral protein immunogens.","brandName":"EDC ConS UFO","companyId":"imperial-college-london","mechanism":{"target":"","novelty":"","modality":"Biologic","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"_claudeStub":{"ts":1779123468,"model":"claude-sonnet-4-5-20250929"},"companyName":"Imperial College London","competitors":[],"description":"EDC ConS UFO is an investigational therapeutic being developed by Imperial College London, currently in Phase 1 clinical testing. Limited public information is available about this early-stage program, including its molecular target, mechanism of action, and intended therapeutic applications.","genericName":"EDC ConS UFO","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}],"offLabel":[],"pipeline":[]},"labelChanges":[],"trialDetails":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"rwe":[],"genericFilers":[],"relatedDrugs":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"modality":"Biologic","enrichmentLevel":2,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}